Zentalis Pharmaceuticals And Tavros Therapeutics Announce Strategic Platform Collaboration To Discover Next Generation Targeted Small Molecule Therapies

Zentalis Pharmaceuticals Inc. published this content on May 28, 2020, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 06, 2026 at 18:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]